NCT02545049 Supported by: Bayer AG Disclosure: M
The question becomes whether the convenience and structure of Optavia justifies the cost when the same nutritional targets are achievable through regular food
A GLP-1 medication might be recommended if you have: Type 2 diabetes and arent meeting your blood sugar goals Struggled with weight loss despite lifestyle changes Conditions like insulin resistance, PCOS, or prediabetes, under guidance of your doctor Always consult with a healthcare provider to determine the right timing and approach for your specific health needs
Lancet 374 , 16061616 (2009)
JAMAs Post JAMA 222,531 followers Report this post Use of GLP-1 agonists for weight loss, compared with use of bupropion-naltrexone, was associated with an increased risk of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease
Zhou J, Geng KK, Ping FF, Gao YY, Liu L, Feng BN